Navigation Links
Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City
Date:7/31/2009

studies in ovarian, breast and colorectal cancer. NKTR-105, PEGylated docetaxel, is currently in a Phase 1 study in patients with refractory solid tumors.

Nektar technology is used in nine approved partnered products in the U.S. or Europe today, including UCB's Cimzia(R), Roche's PEGASYS(R) for hepatitis C and Amgen's Neulasta(R) for neutropenia.

Nektar is headquartered in San Carlos, California, with additional R&D operations in Huntsville, Alabama and Hyderabad, India. 

    Contacts:
    Jennifer Ruddock
    Nektar Therapeutics
    650-631-4954

    Susan Noonan
    The SAN Group
    212-966-3650


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
3. Nektar Therapeutics Reports First Quarter 2009 Financial Results
4. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
5. Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
6. Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets
7. Nektar Announces Retirement of Irwin Lerner from Board of Directors
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
9. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
10. Nektar Therapeutics to Webcast R&D Day on November 12th
11. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...d,s Top Gene Synthesis Companies Form Internationa...est Practices in Risk Reduction ,Five Member Com...hesis Capacity , (PRWEB) ...ding gene synthesis companies today announced agre...ocol to promote biosecurity in the gene synthesis ...
(Date:11/18/2009)...to be able to find explosive materials and persons...earches, the National Institute of Standards and T... of Homeland Security, has developed a new certifi... (SRM) 2905, Trace Particulate Explosives. Compati...RM will be helpful in calibrating, testing and dev...
(Date:11/18/2009).... 18 Masimo (Nasdaq: ...Measure-Through Motion and Low-Perfusion pulse oxi....H.A., one of the largest healthcare Group Purchas...lti-year purchasing agreement for "gold standard" ... offers preferred contract pricing to Uni.H.A.,s 5...
(Date:11/18/2009)...la., Nov. 18 Algenol Biofuels LLC,... and the technology group The Linde Group have a...t in order to identify the optimum management of c...unique algae and photobioreactor technology. This ...develop cost-efficient technologies that capture, ...
Breaking Biology Technology:World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4New NIST trace explosives standard slated for homeland security duty 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 2Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 3
...o support creation of market incentives and facili... BIO Ventures for Global,Health (BVGH) today anno...,expanded its support of the organization, so it c...n to create new medicines for infectious,diseases ... help BVGH build,the market case for biotechnology...
...O, Oct. 14 Althea Technologies, Inc., a leading,p...r pharmaceutical,development and manufacturing, an...two fast growth awards, Deloitte LLP,s San Diego T...al 100 Fastest Growing Private Companies,for the f...t 50 is an,annual ranking of the 50 fastest growin...
...TON, Ill. --- Nanotechnology offers unique opportu...g the delivery, manipulation and observation of bi...The ability to pattern nanoscale arrays of biologi...cs and cell adhesion, and may be applied to achiev...ase detection, even when sample volumes are severe...
Other Biology Technology:BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World 2Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year 2Researchers write protein nanoarrays using a fountain pen and electric fields 2Researchers write protein nanoarrays using a fountain pen and electric fields 3
(Date:11/19/2009)...ov. 19, 2009 -- Sustainable farming, initially ado...ns, may also play a role in maintaining a healthy ...t of Energy,s Oak Ridge and Los Alamos national la...ring the large potential of the earth,s soils to s...land-use practices could greatly reduce U.S. carbo...
(Date:11/19/2009)...versity of Cincinnati professor of paleontology in...uthor Michael Foote of the University of Chicago p...ence with their paper, "Epicontinental Seas Versu...tion and Origination." , For many years, paleobi...biodiversity have focused on charting the many ups...
(Date:11/19/2009)...ohn Fisher, associate professor in the Fischell De...Pitch at the 2009 Bioscience Research and Technolo... system that grows bone and other types of tissue ...of six innovations presented in an eight minute pi...e Professor Venture Fair, held November 12 at the ...
Breaking Biology News(10 mins):ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Bioreactor for bone tissue engineering wins professor venture fair 2Bioreactor for bone tissue engineering wins professor venture fair 3Study finds adverse effects in treatment for primary sclerosing cholangitis 54858 1Study finds adverse effects in treatment for primary sclerosing cholangitis 54858 2Eureka 21 Air cargo scanning wins top prize 9615 1Confronting Health Disparities Among Lesbian Gay Bisexual and Transgender Youth 54856 1Confronting Health Disparities Among Lesbian Gay Bisexual and Transgender Youth 54856 2Confronting Health Disparities Among Lesbian Gay Bisexual and Transgender Youth 54856 3
..., Researchers at Washington University in St. Lou... way circadian rhythms govern global gene expressi...reen alga) known to cycle between photosynthesis d...In general, this study shows that during the day, ... photosynthesis and sugar production, as expected....
..., CHAPEL HILL Its long been known that patients ...aped red blood cells which are normally disc-shap...ey block small blood vessels. , Now, researchers ... School of Medicine have shown that blood from sic...tes, of red and white blood cells that may contrib...
..., CHICAGO - A novel cell therapy using retinal pi...tin bead microcarriers implanted in the brain can ...advanced Parkinsons disease (PD). , Rush Universi... and colleagues from Emory University, Atlanta fou...atients experienced improvement in Parkinsonian sy...
Other Biology News:Single-celled bacterium works 24-7 2Single-celled bacterium works 24-7 3Clumps of red and white blood cells may contribute to sickle cell disease 2Cell-based therapy shows promise in patients with Parkinson's disease 2Cell-based therapy shows promise in patients with Parkinson's disease 3
Mouse Anti-Rat ICAM Monoclonal Antibody, PE Conjugated from Antigenix America Inc.
Rabbit Anti-Human ZAP70, phospho (Tyr319) Monoclonal Antibody, Unconjugated, Clone E227 from Abcam
Rabbit Anti-Bag5 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human VEZT Polyclonal Antibody, Unconjugated from Abcam
Biology Products: